Osaic Holdings’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Osaic Holdings's VIR Position: Q3 2026 in Review
Osaic Holdings reduced its Vir Biotechnology (VIR) stake by 2.6% in Q3 2026, selling an estimated $1.08K and leaving 4,060 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5598.
Osaic Holdings first reported a position in VIR in Q1 2020 and has held it in 27 quarters since. The position peaked at $523K in Q4 2020. 265 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Osaic Holdings held 4,060 shares of Vir Biotechnology worth $44.8K as of Q3 2026.
- Osaic Holdings sold 108 Vir Biotechnology shares in Q3 2026, an estimated $1.08K.
- Vir Biotechnology made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5598 holding.
- Osaic Holdings first reported a position in Vir Biotechnology in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Vir Biotechnology position peaked at $523K in Q4 2020.
- 265 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.